(Q51974615)

19 April 2018

title

Two-year outcome in first-episode psychosis treated according to an integrated model. Is immediate neuroleptisation always needed? (English)

1 reference

19 April 2018

1 reference

Lehtinen V

1

1 reference

19 April 2018

Aaltonen J

2

1 reference

19 April 2018

Koffert T

3

1 reference

19 April 2018

Räkköläinen V

4

1 reference

19 April 2018

Syvälahti E

5

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 August 2000

1 reference

19 April 2018

published in

European Psychiatry

1 reference

19 April 2018

volume

15

1 reference

19 April 2018

issue

5

1 reference

19 April 2018

page(s)

312-320

1 reference

19 April 2018

Psychopharmacologic treatment of schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

Finnish Consensus Development Conference on the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

The rationale and ethics of medication-free research in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

Maintenance of grip on life and goals of life: a valuable criterion for evaluating outcome in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

Towards need-specific treatment of schizophrenic psychoses.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

The Natural Course of Schizophrenia: A Review of First-admission Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

Research in schizophrenia and the discontinuation of antipsychotic medications

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

One year after discharge: community adjustment of schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

Risks of withdrawing antipsychotic medications.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

A comprehensive psychopathological rating scale

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

The risk of medication-free research

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

The treatment of acute schizophrenia without drugs: an investigation of some current assumptions

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

A Non-neuroleptic Treatment for Schizophrenia: Analysis of the Two-year Postdischarge Risk of Relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

Circumplex model of marital and family systems: VI. Theoretical update

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

Research update on the psychosocial treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

Are There Schizophrenics for Whom Drugs May be Unnecessary or Contraindicated?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

Neuroleptics and the Natural Course of Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

Antipsychotic drugs: clinical pharmacology and therapeutic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900400-4

7 January 2021

10.1016/S0924-9338(00)00400-4

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018